Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Laura W. Dillon"'
Autor:
Laura W. Dillon, Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H. Smith, Elizabeth Schmidt, Charles C. Valentine III, Jesse J. Salk, Brent L Wood, Harry P. Erba, Jerald P. Radich, Christopher S. Hourigan
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
The presence of measurable residual disease (MRD) is strongly associated with treatment outcomes in acute myeloid leukemia (AML). Despite the correlation with clinical outcomes, MRD assessment has yet to be standardized or routinely incorporated into
Externí odkaz:
https://doaj.org/article/5ddca69089a4412bafc0c569c3e4ed97
Autor:
Benjamin D. Solomon, Hong Zheng, Laura W. Dillon, Jason D. Goldman, Christopher S. Hourigan, James R. Heath, Purvesh Khatri
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The human leukocyte antigen (HLA) locus plays a central role in adaptive immune function and has significant clinical implications for tissue transplant compatibility and allelic disease associations. Studies using bulk-cell RNA sequencing have demon
Externí odkaz:
https://doaj.org/article/7516530fde044040b542109bdcbf9624
Autor:
Fernanda Gutierrez-Rodrigues, Isabel Beerman, Emma M. Groarke, Bhavisha A. Patel, Nina Spitofsky, Laura W. Dillon, Diego Quinones Raffo, Christopher S. Hourigan, Sachiko Kajigaya, Luigi Ferrucci, Neal S. Young
Publikováno v:
Haematologica, Vol 107, Iss 8 (2021)
Although cell-free DNA (cfDNA) tests have emerged as a potential non-invasive alternative to bone marrow biopsies for monitoring clonal hematopoiesis in hematologic diseases, whether commercial cfDNA assays can be implemented for the detection and qu
Externí odkaz:
https://doaj.org/article/d21f73a480b347d6bbef0f5a340c1989
Autor:
Laura W. Dillon, Sheida Hayati, Gregory W. Roloff, Ilker Tunc, Mehdi Pirooznia, Antonina Mitrofanova, Christopher S. Hourigan
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
Great effort is spent on developing therapies to improve the dire outcomes of those diagnosed with acute myeloid leukemia. The methods for quantifying response to therapeutic intervention have however lacked sensitivity. Patients achieving a complete
Externí odkaz:
https://doaj.org/article/f826235f99c848bc954f2aaadddf2b30
Autor:
Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Publikováno v:
Frontiers in Oncology, Vol 8 (2019)
Measurable residual disease (MRD) testing after initial chemotherapy treatment can predict relapse and survival in acute myeloid leukemia (AML). However, it has not been established if repeat molecular or genetic testing during chemotherapy can offer
Externí odkaz:
https://doaj.org/article/fa6ebebba15a441496da6f117f43dcad
Autor:
Laura W. Dillon, Pankaj Kumar, Yoshiyuki Shibata, Yuh-Hwa Wang, Smaranda Willcox, Jack D. Griffith, Yves Pommier, Shunichi Takeda, Anindya Dutta
Publikováno v:
Cell Reports, Vol 11, Iss 11, Pp 1749-1759 (2015)
MicroDNAs are
Externí odkaz:
https://doaj.org/article/d9d44a78be4141a59b2fb57b3a4703ff
Publikováno v:
Journal of Clinical Medicine, Vol 6, Iss 9, p 87 (2017)
Outcomes for those diagnosed with acute myeloid leukemia (AML) remain poor. It has been widely established that persistent residual leukemic burden, often referred to as measurable or minimal residual disease (MRD), after induction therapy or at the
Externí odkaz:
https://doaj.org/article/c7cc3564067446da9b22176f87da8469
Publikováno v:
Journal of Thyroid Research, Vol 2012 (2012)
The incidence of thyroid cancer is increasing, especially papillary thyroid carcinoma (PTC), making it currently the fastest-growing cancer among women. Reasons for this increase remain unclear, but several risk factors including radiation exposure a
Externí odkaz:
https://doaj.org/article/f292ab5fc7e84a6ea39021f6510539e9
Autor:
James L Gulley, Thomas Hughes, Jennifer L Marté, Katherine R Calvo, Meghali Goswami, Christopher S Hourigan, Gege Gui, Laura W Dillon, Katherine E Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y Ghannam, Karolyn A Oetjen, Christin B Destefano, Dana M Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, Catherine Lai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/45b9aa3831424071877f408309fd9bea
Autor:
Christopher S. Hourigan, Yuesheng Li, Patrick Burr, J. Philip McCoy, Pradeep K. Dagur, Aik Ooi, Shu Wang, Saurabh Gulati, Aaron Llanso, Robert Durruthy-Durruthy, Adam Sciambi, Catherine Lai, Christin B. DeStefano, Janet Valdez, Julie Thompson, Clifton L. Dalgard, Gauthaman Sukumar, Anthony R. Soltis, Matthew D. Wilkerson, Karolyn A. Oetjen, Katherine E. Lindblad, Katherine R. Calvo, Meghali Goswami, Gege Gui, Chidera Nosiri, Jack Ghannam, Laura W. Dillon
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::583a4abaca0e1f1ff84cf805f24cfeb0
https://doi.org/10.1158/2643-3230.22543308.v1
https://doi.org/10.1158/2643-3230.22543308.v1